Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-10-13 14:55Core Viewpoint - The recent announcement by the company regarding the unlocking of the second phase of its employee stock ownership plan indicates a strategic move to align employee interests with company performance, while also reflecting on the company's current stock performance and market valuation [1]. Group 1: Stock Performance - As of October 13, 2025, the stock price of the company is 38.53 yuan, down 2.31% from the previous trading day [1]. - The stock opened at 38.68 yuan, reached a high of 38.95 yuan, and a low of 38.27 yuan, with a trading volume of 2.04 billion yuan and a turnover rate of 0.91% [1]. Group 2: Employee Stock Ownership Plan - The second lock-up period of the company's first employee stock ownership plan ended on October 11, 2025, with the unlocking conditions met [1]. - The stock is unlocked in three phases, with the second phase allowing for 30% of the total shares held under the plan to be released [1]. - As of October 11, 2023, 505,000 shares have been transferred to the employee stock ownership plan account, with 143,071 shares eligible for unlocking, representing approximately 0.02% of the company's total share capital [1]. - The actual number of shares allocated to holders will depend on performance evaluations, categorized as excellent, good, qualified, and unqualified, corresponding to allocation ratios of 100%, 80%, 50%, and 0% respectively [1]. - The management committee will sell the vested shares in compliance with regulatory requirements, and the board's compensation and assessment committee believes this unlocking aligns with regulations and does not harm the interests of the company and its shareholders [1].